Target intelligence / Profile preview

TATA-box binding protein-like 2 (TBPL2)

Target
TBPL2
Molecular classification
Transcription factor, General transcription factor
01

Overview

TATA-box binding protein-like 2 (TBPL2, also known as TBP-related factor 3/TRF3) is a vertebrate-specific member of the TATA-binding protein family that participates in transcription initiation by binding to the TATA-box motif in gene promoters and interacting with core transcription machinery such as TFIIA and TFIIB[1][2][4]. TBPL2 is most highly expressed in oocytes, where it replaces conventional TBP to support oocyte-specific transcription programs necessary for folliculogenesis and fertility. The protein is highly homologous with TBP in its C-terminal DNA-binding domain (95% identity), but its N-terminal domain is divergent, allowing specialization for oocyte function[1][2][4]. Loss of TBPL2 does not cause gross developmental abnormalities but leads to infertility in female mice due to defective folliculogenesis[1]. TBPL2 is not known to be a direct drug target in current therapeutic contexts.

Other names
TBP-related factor 3TRF3TBP2TATA box-binding protein-like 2TBP-like 2TATA box-binding protein-related factor 3TBP-like protein 2
02

Mechanism of action

Not established; generic mechanism for potential drug: inhibition or modulation of DNA binding or transcription factor recruitment.

03

Biological functions

Transcription initiationBinding to the TATA box in promoter DNAInteraction with other basal transcription factors, such as TFIIA and TFIIBRegulation of oocyte-specific transcription and folliculogenesisStem cell reprogramming in oogenesis
04

Disease associations

Infertility (defect in folliculogenesis/gametogenesis due to TBPL2 loss)Other (no strong link to cancer, inflammation, or major diseases yet in the literature)
05

Safety considerations

No reported safety concerns or therapeutic challenges, but knock-out results in female infertility in mice, suggesting potential reproductive toxicity risk

Beyond the preview

Go deeper on TATA-box binding protein-like 2 (TBPL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein-like 2 (TBPL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call